Skip To Main Content
Christopher Gregg on Muck Rack

Christopher Gregg

University of Utah
As seen in: Nature, EurekAlert!, Cell Press, Cell Reports, STAT
The Patient-Scientist: Surviving the Data | Benning Chair, Neurogenomics researcher | co-founder: Storyline Health, Primordial Bio, and Uncharted Health
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Exenatide Is Associated with Superior Gastrointestinal Motility Slowing Among GLP-1 Receptor Agonists

|
By Karthik Murugadoss, Christopher Gregg, A. J. Venkatakrishnan
| preprints.org
You are already at the latest version Objectives: Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that slows gastrointestinal (GI) motility. Whether exenatide produces clinically detectable GI motility slowing in real-world practice — and how this compares to other GLP-1 RAs — has not been systematically evaluated. We addressed this question using federated, electronic health record (EHR) data.
Open in Who Shared Issue with article?

Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss

|
By Karthik Murugadoss, A. J. Venkatakrishnan, Christopher Gregg, Venky Soundararajan
| Nature Verified
Abstract Semaglutide is often optimized to maximize weight loss, yet it remains unclear whether long-term cardiovascular benefit is more closely associated with achieved weight reduction or therapeutic exposure. We conducted a retrospective observational study using a federated, de-identified U.S. electronic health record network comprising 47,199 patients with pre-existing cardiovascular disease who initiated semaglutide.
Open in Who Shared Issue with article?

[2407.16909] Using Helium Balloon Flying Drones for Introductory CS Education

|
By Christopher Gregg
| arxiv.org
arXiv:2407.16909 (cs) View PDF Subjects: Computers and Society (cs.CY); Human-Computer Interaction (cs.HC); Robotics (cs.RO) Cite as: arXiv:2407.16909 [cs.CY] (or arXiv:2407.16909v1 [cs.CY] for this version) Submission history From: Stanley Cao [ view email] [v1] Wed, 26 Jun 2024 02:19:44 UTC (1,322 KB) Bibliographic Tools Bibliographic Explorer Toggle Bibliographic Explorer () Litmaps Toggle Litmaps (What is Litmaps?) scite.ai Toggle scite Smart Citations (What are Smart Citations?) Code,...
Open in Who Shared View Duplicates (231) Issue with article?
See all 8 licensed articles (9 Total)